aces high, page-4

Tony,
I note your comment that BEN_0805 and BEN_1312 have been identified from the Roche/Genentech collaboration. We also know from the CFO that;

"[Phylogica is] talking to Genentech about BBBPs and then have a separate discussion with another group in a different field (i.e., two discussions with Genentech but separate areas)."

Do you think that there a connection between BEN_0805, BEN_1312 and the discussions around two further but separate collaborations with Genentech or do you think that it is totally unrelated?

Further, I wonder how many peptides are patented? I know from the website that Phylogica’s patent families cover individual Phylomer® peptides discovered for therapeutic and diagnostic applications. You have noted that BEN_0805 and BEN_1312 have patents but it would be interesting to know the total number of individual phylomer peptides which have been patented? I wonder whether we are talking about several or hundreds or thousands.

Regards,

Wayne.